Инвестиции в Швейцарии Задачи и Услуги Мы информируем потенциальных иностранных инвесторов о преимуществах и рамочных условиях ведения бизнеса в Швейцарии.
News 20 jan 2021 Swiss PharmaCan successfully tests anti-COVID drug Swiss PharmaCan and Australia-based MGC Pharma have successfully concluded phase II clinical testing for their COVID-19 therapeutic candidate, Ar...
Invertir en Suiza Competencias y servicios Informamos a los potenciales inversionistas extranjeros sobre los puntos fuertes y las condiciones marco de Suiza como lugar de establecimiento.
Invest in Switzerland Responsibilities and Services We inform potential foreign investors about the particular strengths and general conditions of Switzerland as a business location.
News 30 juil 2019 Icare opens a subsidiary in Switzerland The French leader in microbiological analyses in the field of industrial health has chosen La Chaux-de-Fonds, in the French-speaking canton of Ne...
Investir na Suíça Competências regionais e serviços Informamos os investidores estrangeiros interessados sobre as condições de base que vigoram na Suíça.
Investieren in die Schweiz Zuständigkeiten und Dienstleistungen Wir informieren potenzielle ausländische Investoren über die besonderen Stärken und Rahmenbedingungen des Wirtschaftsstandorts Schweiz.
Investir en Suisse Compétences et services Nous fournissons aux investisseurs potentiels des informations sur les atouts de la Suisse et sur les conditions-cadres régissant sa place économ...
Investire in Svizzera Competenze e servizi Informiamo i potenziali investitori stranieri sui vantaggi e le condizioni quadro particolari della piazza economica svizzera.
News 30 jan 2018 Cancer drug from Schachen The American pharmaceutical group MSD is producing a new cancer drug in Schachen, in Canton Lucerne.